Sofia, Bulgaria, July 26, 2023 – In accordance with the requirements of art. 100 of LPOS “Sopharma” AD notifies that on July 31, 2023 the Company will initiate the payment of the 2022 dividend of 60 stotinki voted on the Annual General Meeting of Shareholders held on June 2, 2023.

The shareholders eligible for dividend are those registered in the book of shareholders 14 days after the date of the GMS on which the distribution of dividend was voted, i.e. June 16, 2023.

Sofia, Bulgaria, July 20, 2023 – According to the requirements of art. 100t of LPOS, “Sopharma” AD notifies that for the month of June 2023, "Sopharma" AD realized a increase in sales of 9% compared to the same month of the previous year, including 29% increase of domestic sales and and maintaining export sales.

For the first half of 2023, sales increased by a total of 13% incl. 1% decrease of sales for the domestic market and 24% increase in export sales.

Sofia, Bulgaria, July 14, 2023 – According to the requirements of art. 100t of LPOS, “Sopharma” AD notifies that in implementation of a decision of the Board of Directors after a detailed analysis and negotiations, "Sopharma" AD signed a contract for the phased acquisition of the Serbian pharmaceutical manufacturer Pharmanova within two years. The deal is subject to approval by the Serbian Competition Commission and will start with the acquisition of 25% of the Company, followed by the acquisition of 50% after one year and 25% after two years, respectively.